Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
2.490
-0.060 (-2.35%)
Oct 26, 2026, 2:20 PM EDT - Market open
Protalix BioTherapeutics Market Cap
Protalix BioTherapeutics has a market cap or net worth of $200.62 million as of October 26, 2026. It is the 20,476th most valuable company in the world and the 3,546th biggest in the United States. Its market cap has increased by 6.60% in one year.
Market Cap
200.62M
Enterprise Value
169.17M
1-Year Change
6.60%
Global Rank
Country Rank
#3,546 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $200.62M, an increase of 1,600.20%. That is a compound annual growth rate of 10.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 200.62M | 38.55% |
| Dec 31, 2025 | 144.80M | 4.62% |
| Dec 31, 2024 | 138.40M | 6.54% |
| Dec 29, 2023 | 129.90M | 87.18% |
| Dec 30, 2022 | 69.40M | 83.11% |
| Dec 31, 2021 | 37.90M | -68.68% |
| Dec 31, 2020 | 121.00M | 148.46% |
| Dec 31, 2019 | 48.70M | 5.64% |
| Dec 31, 2018 | 46.10M | -50.11% |
| Dec 29, 2017 | 92.40M | 107.64% |
| Dec 30, 2016 | 44.50M | -56.29% |
| Dec 31, 2015 | 101.80M | -40.95% |
| Dec 31, 2014 | 172.40M | -52.64% |
| Dec 31, 2013 | 364.00M | -24.96% |
| Dec 31, 2012 | 485.10M | 14.93% |
| Dec 30, 2011 | 422.10M | -47.92% |
| Dec 31, 2010 | 810.50M | 58.46% |
| Dec 31, 2009 | 511.50M | 266.14% |
| Dec 31, 2008 | 139.70M | -45.71% |
| Dec 31, 2007 | 257.30M | 2,552.58% |
| Dec 29, 2006 | 9.70M | -21.77% |
| Dec 30, 2005 | 12.40M | 1,671.43% |
| Dec 31, 2004 | 700.00K | -41.67% |
| Dec 31, 2003 | 1.20M | 300.00% |
| Dec 31, 2002 | 300.00K | -57.14% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexeo Therapeutics | 229.72M |
| Sol-Gel Technologies | 227.38M |
| Keros Therapeutics | 223.65M |
| BridgeBio Oncology Therapeutics | 213.26M |
| Zentalis Pharmaceuticals | 209.22M |
| Camp4 Therapeutics | 207.09M |
| Pyxis Oncology | 200.69M |
| Eledon Pharmaceuticals | 187.09M |